ARMISTICE CAPITAL, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Calidi Biotherapeutics, Inc. Common Stock, par value $0.0001 per share (CLDI)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Calidi Biotherapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: CLDI
Shares outstanding: 2,352,064 shares
Disclosed Ownership: 117,368 shares
Ownership: 5%
Form type: SCHEDULE 13G/A
Filing time: 14 Aug 2025, 21:05:27 UTC
Date of event: 30 Jun 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	5%	117,368	0	117,368	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	5%	117,368	0	117,368	/s/ Steven Boyd	Steven Boyd